Thomas had tumours in his brain and spinal cord. Now look at him! (IMAGE)
Caption
Thomas Edney was 2.5 when he was admitted into hospital with tumors in his brain and spinal cord. Multiple diagnoses and a failure to improve led him to the ZERO program which showed a mutation believed to be driving Thomas' cancer. The ZERO team was able to find a therapy capable of targeting the mutation. In November 2019, Thomas was able to access a pediatric clinical trial using a gene therapy drug called Afatinib. Thomas's acceptance into the trial was only possible due to the ZERO program which included personalized analysis of Thomas' tumor sample. In January 2020, after two months of treatment, Thomas' brain scan showed a noticeable improvement. Today, Thomas is eight years old and still receiving the therapy. His tumour has shrunk, and he is no longer in debilitating pain.
Credit
Children's Cancer Institute
Usage Restrictions
None
License
Licensed content